Author Question: On average, how long does the diagnosis of idiopathic pulmonary artery hypertension (IPAH) follow ... (Read 62 times)

nummyann

  • Hero Member
  • *****
  • Posts: 576
On average, how long does the diagnosis of idiopathic pulmonary artery hypertension (IPAH) follow the onset of the disease?
 
  a. 6 months
  b. 1 year
  c. 18 months
  d. 2 years

Question 2

What is the initial event in the pathogenesis of idiopathic pulmonary artery hypertension (IPAH)?
 
  a. Insult to the pulmonary endothelium
  b. Elevated level of serotonin
  c. Monoclonal proliferation of endothelial cells
  d. Vascular remodeling



parshano

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

ANS: D
On average, the diagnosis of IPAH is delayed for 2 years after the onset of IPAH.

Answer to Question 2

ANS: A
The initial event of IPAH is probably an insult to the pulmonary endothelium (the cells that line the blood vessel).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library